HOME >> BIOLOGY >> NEWS
The World Economic Forum announces new class of technology pioneers for 2006: Ossur selected

a critical role in driving the company towards reaching its goals.
  • Status. The company must not currently be a Member of the World Economic Forum. This criterion applies to the parent company thus wholly-owned subsidiaries of large firms are not eligible.
  • Nominees are evaluated by an external review committee comprised of technology experts with respect to the criteria above.

    In 2005, Ossur single-handedly transformed the nature of prosthetics with the launch of Bionic Technology by Ossur, a new technology platform which pushes the boundary of existing functional capabilities. Founded upon an interdiciplinary and precise fusion of electronics, mechanics, and human physiology, this new range of products includes Ossur's new products: the RHEO KNEETM and the POWER KNEETM, and will soon address the orthopedic market, as well. The goals are to remove the physical limitations caused by a patient's disability; remove the morbidity inherent in some conventional designs; and make the technology available to a wider group of patients.

    The uniqueness of the Technology Pioneer network ensures that companies involved in the development of new technologies are engaged in an integrated and interdisciplinary way. The Technology Pioneers community will provide the Foundation and its members with in-depth knowledge of some of the key technology issues facing society.


    '"/>

    Contact: Beverly Millson
    beverly@missingsock.com
    310-399-7599
    Ossur
    4-Dec-2005


    Page: 1 2 3

    Related biology news :

    1. World Wildlife Fund warns against iron dumping experiment near the Galapagos Islands
    2. Worlds first X-ray free electron laser is on course to completion
    3. Worlds leading scientists announce creation of Encyclopedia of Life
    4. Prize winners announced at ISNs World Congress of Nephrology
    5. World first test potential to identify breast cancer patients who will react badly to radiotherapy
    6. Worlds top engineers in San Antonio for system of systems conference
    7. OneWorld Health selects Odyssey Research for phase 4 study in India
    8. MicrobeWorld podcast wins another award
    9. International Astronautical Federation joins project to protect World Heritage sites
    10. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
    11. Nature Genetics and the International Society of Nephrology come to Danvers on World Kidney Day

    Post Your Comments:
    (Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
    (Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
    (Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
    Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
    (Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
    (Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
    (Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
    (Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest will ask ... to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge 2015 will ... and a period of expert mentorship from a senior industry figure drawn from the ...
    Breaking Biology Technology:Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
    Cached News: